Cargando…
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
Ménétriere´s disease is a rare disorder of the body and fundus of the stomach, characterized by a massive proliferation of the foveolar cells and subsequent excess mucous secretion. This results in hypoproteinemia due to loss of serum proteins across the gastric mucosa. The cause of Ménétriere´s dis...
Autores principales: | Carlsen, Arne, Grimstad, Tore Bjørn, Karlsen, Lars Normann, Greve, Ole Jacob, Norheim, Katrine Brække, Lea, Dordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885025/ https://www.ncbi.nlm.nih.gov/pubmed/31123980 http://dx.doi.org/10.1007/s12328-019-00994-8 |
Ejemplares similares
-
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
por: Steinsbø, Øyvind, et al.
Publicado: (2022) -
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn’s disease
por: Carlsen, Arne, et al.
Publicado: (2018) -
Determination of lower cut‐off levels of adalimumab associated with biochemical remission in Crohn's disease
por: Carlsen, Arne, et al.
Publicado: (2019) -
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
por: Lee, Carol M, et al.
Publicado: (2010) -
Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
por: Norheim, Katrine Brække, et al.
Publicado: (2012)